EMG
SRDX

Ellington Management Group’s Surmodics SRDX Stock Holding History

Ellington Management Group’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,300
Closed -$261K – 745
2019
Q4 		$261K Buy
+6,300
New +$265K 0.06% 356
2018
Q3 		– Sell
-5,000
Closed -$276K – 660
2018
Q2 		$276K Buy
+5,000
New +$231K 0.02% 302
2013
Q4 		– Sell
-8,700
Closed -$207K – 774
2013
Q3 		$207K Sell
8,700
-3,500
-29% -$75K 0.04% 659
2013
Q2 		$244K Buy
+12,200
New +$305K 0.05% 593

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Ellington Management Group's SRDX Position: Q1 2020 in Review

Ellington Management Group sold out of Surmodics (SRDX) in Q1 2020, closing a stake of 6,300 shares — an estimated $261K sold.

Ellington Management Group first reported a position in SRDX in Q2 2013 and held it in 4 quarters. The position peaked at $276K in Q2 2018. 127 funds tracked by Wall St. Rank hold SRDX as of Q1 2020.

  • Ellington Management Group reported no remaining Surmodics position as of Q1 2020 after selling out during the quarter.
  • Ellington Management Group sold 6,300 Surmodics shares in Q1 2020, an estimated $261K.
  • Ellington Management Group first reported a position in Surmodics in Q2 2013 and held it in 4 quarters.
  • Ellington Management Group's Surmodics position peaked at $276K in Q2 2018.
  • 127 funds tracked by Wall St. Rank held Surmodics as of Q1 2020.

Based on Ellington Management Group's 13F filing for Q1 2020, filed 15 May 2020.